How Institutional Funds Moved on INBX

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC increased this position by 286% ($17,132,019 -> $66,096,272). 2026-06-30
PERCEPTIVE ADVISORS LLC PERCEPTIVE ADVISORS LLC increased this position by 27% ($96,993,192 -> $122,963,044). 2026-06-30
Parkman Healthcare Partners LLC Parkman Healthcare Partners LLC opened a new position worth $24,346,013. 2026-06-30
GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC increased this position by 359% ($5,610,344 -> $25,777,685). 2026-06-30
Sanofi Sanofi increased this position by 20% ($91,476,154 -> $109,713,489). 2026-06-30
First Turn Management, LLC First Turn Management, LLC opened a new position worth $15,613,189. 2026-06-30
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND increased this position by 124% ($11,476,161 -> $25,743,575). 2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC VANGUARD CAPITAL MANAGEMENT LLC increased this position by 43% ($32,702,151 -> $46,662,196). 2026-06-30

Which Funds Hold INBX

Largest reported positions as of 2026-06-30.

FundValueShares
PERCEPTIVE ADVISORS LLC $122,963,044 1,297,763
Sanofi $109,713,489 1,157,926
VIKING GLOBAL INVESTORS LP $106,492,273 1,123,929
HighTower Advisors, LLC $82,484,676 870,551
BANK OF AMERICA CORP /DE/ $78,813,808 831,808
Schonfeld Strategic Advisors LLC $66,096,272 697,586
VANGUARD CAPITAL MANAGEMENT LLC $46,662,196 492,477
Woodline Partners LP $37,984,517 400,892
Capital Research Global Investors $34,398,988 363,050
PFM Health Sciences, LP $29,219,479 308,385

Data compiled from public SEC filings. This is informational reporting, not investment advice.

Sanofi’s 13F Portfolio Moves, Tracked Quarter by Quarter

Table-style overview of Sanofi's 13F portfolio changes for the quarter ending June 30, 2026, showing new positions in AGMB, ODTX, and TRAX, increases in MGTX, NVAX, INBX, MPLT, ANAB, and QTTB, a reduction in IMRX, and an exit from Eledon.

This page tracks Sanofi’s institutional portfolio activity as disclosed in its quarterly Form 13F filings with the SEC. Rather than a one-off news snapshot, think of it as a running ledger — new positions, exits, and size changes get logged here every quarter so you can see how the company’s biotech and pharma stakes shift … Read more